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Abstract 
We report an extremely rare case of small intestinal cancer metastasized to the urinary 
bladder, presenting a urologic symptom. A 41-year-old man first presented with nausea, 
vomiting and abdominal pain. Based on the clinical diagnosis of jejunal cancer, he 
underwent a partial resection of the jejunum with lymph node dissection. The 
pathological diagnosis was moderately differentiated adenocarcinoma of the jejunum, 
pT4N0. Seventeen months after surgery, he presented with a gross hematuria. Computed 
tomographic scan showed wall thickening of the posterior wall of the urinary bladder. No 
tumor was found in other organs or lymph nodes. Based on histological and 
immunohistochemical analysis, the diagnosis of urinary bladder metastasis from jejunal 
adenocarcinoma was made. This is the first report of urinary bladder metastasis from 
small intestinal cancer. Although very rare, the possibility of metastatic small intestinal 
cancer should be considered in differential diagnosis in patients with adenocarcinoma 
involving the urinary bladder. 
 
Introduction 
Cancer of the small intestine is rare. While the small intestine constitutes 90% of the 
absorptive area of the gastrointestinal tract, malignant tumors of the colon and rectum are 
50 times more common [1]. Common metastatic sites of small intestinal cancer are 
regional lymph nodes and liver [2]. We report an extremely rare case of solitary urinary 
bladder metastasis from small intestinal cancer, presenting a urologic symptom.  
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Case Report 
A 41-year-old man was admitted to the hospital because of nausea, vomiting and abdominal pain. 
While upper gastrointestinal endoscopy showed no significant finding, computed tomographic scan 
showed wall thickening of the upper small intestine. Fluoroscopic examination of the small intestine 
revealed a tumor mass in the jejunum 20 to 30 cm distal from the ligament of Treitz. Endoscopy of the 
small intestine with biopsy was performed and the tumor was diagnosed as adenocarcinoma. Large 
intestinal endoscopy showed no significant finding. He underwent a partial resection of the jejunum 
with lymph node dissection. The surgical specimen showed a 5.0 × 4.5 cm-sized tumor mass in the 
jejunum, obstructing the intestinal tract (fig. 1). The pathological diagnosis was moderately 
differentiated adenocarcinoma of the jejunum. The tumor invaded beyond the serosa of jejunum (pT4) 
without lymph node metastasis (pN0). He did not receive any adjuvant therapy and was followed up as 
an outpatient. 
Seventeen months after surgery, he presented with a gross hematuria. Computed tomographic scan 
showed wall thickening of the posterior wall of the urinary bladder (fig. 2). No tumor was found in 
other organs or lymph nodes. Transurethral resection biopsy of the bladder tumor was performed, and 
the histological analysis showed enteric-type adenocarcinoma similar to the primary jejunal 
adenocarcinoma (fig. 3). No urothelial carcinoma component was found. Immunohistochemically, 
both the jejunal cancer cells and bladder cancer cells were positive for cytokeratin 20, CDX-2, p53 and 
carcinoembryonic antigen, and negative for cytokeratin 7 and thrombomodulin. The diagnosis of 
urinary bladder metastasis from jejunal adenocarcinoma was made. He was subsequently treated with 
chemotherapy (weekly paclitaxel) and a partial response was observed. However, he died from 
widespread metastases 25 months after the diagnosis of bladder metastasis. 
Discussion 
Metastatic urinary bladder tumors are rare, accounting for less than 2% of all bladder 
tumors [3], and are almost always associated with widely disseminated disease [4]. Most 
secondary bladder tumors represent direct invasion by tumors originating in an adjacent 
site, most commonly the female genital tract, prostate, colon and rectum [3]. A smaller 
proportion are metastases, most commonly from the skin (malignant melanoma), 
stomach, breast, or lung [3, 5, 6]. Melicow [3] examined 1,614 surgically resected bladder 
tumor cases and found 25 (1.5%) metastatic tumors. The sites of origin were stomach (11 
cases), breast (9 cases), lung (4 cases) and skin (1 case). Sheehan et al. [5] found 21 (0.4%) 
metastatic bladder tumors in a series of 5,200 male autopsies in a single institution. The 
sites of origin were skin (8 cases), stomach (6 cases), lung (5 cases), pancreas (1 case) and 
colon (1 case). Although some other primary sites were reported [6, 7], to the best of our 
knowledge, this is the first report of urinary bladder metastasis from small intestinal 
cancer. 
The distinction between a primary bladder adenocarcinoma and a secondary tumor 
involving the bladder is of great clinical importance in terms of staging, determining 
appropriate therapy, and assessing prognosis. Some immunohistochemical markers are 
reported to be of diagnostic value in the distinction between primary adenocarcinoma of 
the bladder and secondary intestinal adenocarcinoma [8–10]. Our immunohistochemical 
results on this case were compatible with secondary intestinal adenocarcinoma. The 
combination of clinical history, histological and immunohistochemical studies could 
confirm the diagnosis of bladder metastasis from small intestinal cancer in this case. 
In the present case, small intestinal cancer metastasized only to the urinary bladder at 
the time of diagnosis, although most reported patients with metastatic bladder tumor 
have other sites of involvement [4, 5]. In practice, knowledge of a history of tumor  
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elsewhere and comparison with the original histology will establish the secondary nature 
of a bladder tumor in many cases. However, metastatic bladder tumor may be the first 
presentation [11]. Therefore, in cases where the histological findings do not clearly 
identify the bladder tumor as primary, investigation for tumor at other likely sites of 
origin is advisable. Particularly in case enteric-type adenocarcinoma involves the urinary 
bladder and no tumor is found by traditional large intestinal or upper gastrointestinal 
endoscopy, the possibility of small intestinal cancer should be considered and imaging 
studies should be performed. 
In conclusion, we reported a previously unreported case of urinary bladder metastasis 
from small intestinal cancer. Although very rare, the possibility of metastatic small 
intestinal cancer should be considered in differential diagnosis in patients with 
adenocarcinoma involving the urinary bladder. 
 
 
 
 
 
 
Fig. 1. Gross appearance of the jejunal tumor. A tumor mass with central ulceration is obstructing the 
intestinal tract (arrow). Inset: cut surface of the tumor. A whitish solid tumor invades beyond the 
muscularis propria of the jejunum to the mesentery (arrowhead). 
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Fig. 2. Computed tomographic scan shows wall thickening of the posterior wall of the urinary bladder 
(arrow). 
 
 
 
Fig. 3. Histological section of the bladder tumor shows enteric-type adenocarcinoma. Bar: 0.1 mm. 
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